APA

Lehmann-Che J., Hamy A., Porcher R., Barritault M., Bouhidel F., Habuellelah H., Leman-Detours S., de Roquancourt A., Cahen-Doidy L., Bourstyn E., de Cremoux P., de Bazelaire C., Albiter M., Giacchetti S., Cuvier C., Janin A., Espié M., de Thé H. & Bertheau P. (20150312). Molecular apocrine breast cancers are aggressive estrogen receptor negative tumors overexpressing either HER2 or GCDFP15. : Breast cancer research : BCR.

Chicago

Lehmann-Che Jacqueline, Hamy Anne-Sophie, Porcher Raphaël, Barritault Marc, Bouhidel Fatiha, Habuellelah Hanadi, Leman-Detours Solenne, de Roquancourt Anne, Cahen-Doidy Laurence, Bourstyn Edwige, de Cremoux Patricia, de Bazelaire Cedric, Albiter Marcela, Giacchetti Sylvie, Cuvier Caroline, Janin Anne, Espié Marc, de Thé Hugues and Bertheau Philippe. 20150312. Molecular apocrine breast cancers are aggressive estrogen receptor negative tumors overexpressing either HER2 or GCDFP15. : Breast cancer research : BCR.

Harvard

Lehmann-Che J., Hamy A., Porcher R., Barritault M., Bouhidel F., Habuellelah H., Leman-Detours S., de Roquancourt A., Cahen-Doidy L., Bourstyn E., de Cremoux P., de Bazelaire C., Albiter M., Giacchetti S., Cuvier C., Janin A., Espié M., de Thé H. and Bertheau P. (20150312). Molecular apocrine breast cancers are aggressive estrogen receptor negative tumors overexpressing either HER2 or GCDFP15. : Breast cancer research : BCR.

MLA

Lehmann-Che Jacqueline, Hamy Anne-Sophie, Porcher Raphaël, Barritault Marc, Bouhidel Fatiha, Habuellelah Hanadi, Leman-Detours Solenne, de Roquancourt Anne, Cahen-Doidy Laurence, Bourstyn Edwige, de Cremoux Patricia, de Bazelaire Cedric, Albiter Marcela, Giacchetti Sylvie, Cuvier Caroline, Janin Anne, Espié Marc, de Thé Hugues and Bertheau Philippe. Molecular apocrine breast cancers are aggressive estrogen receptor negative tumors overexpressing either HER2 or GCDFP15. : Breast cancer research : BCR. 20150312.